TMS treatment is conducted using a device called the NeuroStar TMS Therapy System.
While treatment is administered, patients remain awake while sitting in a comfortable reclining chair.
Each TMS therapy session is a 40-minute outpatient procedure that is prescribed by a psychiatrist, does not require anesthesia or sedation, and patients remain awake and alert. The treatment is typically administered daily for 4 to 6 weeks and the patient is able to maintain their normal routine before and after beginning TMS therapy.
TMS therapy stimulates nerve cells in an area of the brain believed to be linked to depression. A treatment coil is applied to the patient’s head through which the NeuroStar TMS therapy system generates highly concentrated magnetic field pulses that turn on and off rapidly. The pulses continue for the duration of the session.
FDA Approved in 2008 for the treatment of depression.
- Does not require anesthesia.
- Non invasive.
- Well tolerated.
- Can be done entirely as an outpatient and can drive self to and from the treatment as well as continue normal daily routines, including work, even on treatment days.
- Current data has demonstrated efficacy in patients who have struggled with medication efficacy for their depression.
- May be good alternative for patients who responded to ECT in past.
- No significant memory impairment.